Delivery Order 75N91018D00014-75N91020F00001

This is a federal contract award by the National Cancer Institute (NCI), a civilian agency, to the University of Utah for the Surveillance, Epidemiology, and End Results (SEER) - Pediatric Cancer Whole Slide Imaging program. The contract has a total potential value of $106,688.19 and a period of performance through December 30, 2021. The contract is a delivery order with a cost-no-fee pricing type. There is no set-aside designation. The University of Utah, a U.S. state government entity and...

This federal contract award is for a Surveillance, Epidemiology, and End Results (SEER) Pediatric Cancer Whole Slide Imaging Pilot, awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Louisiana State University Health Sciences Center New Orleans (LSU Health Sciences Center New Orleans). The contract is a Delivery Order under the SEER Master IDIQ contract, with a potential value of $179,919.00 and a period of performance from August...

The Department of Health and Human Services Food and Drug Administration awarded a $320,560 firm fixed price purchase order to Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, to procure 150 glass pathology slides stained with hematoxylin and eosin from triple negative breast cancer patients within the last seven years. The slides are being acquired under solicitation CDRH-2023-118641 to support the agency's efforts to create datasets that validate digital...

The University of California, San Francisco (UCSF) has been awarded a $155,104.99 delivery order contract by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH). The contract is part of the Surveillance, Epidemiology, and End Results (SEER) Program, which aims to collect and analyze data on cancer incidence and survival in the United States. Under this contract, UCSF will conduct a pilot project to develop and implement whole slide imaging capabilities for...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the University Health Network (UHN), doing business as the Toronto General And Western Hospital Foundation, to procure existing clinical and treatment data on at least 500 pediatric cancer patients treated with photon therapy since 2007. The contract, valued at $97,021.21, is part of the NCI's Cancer Genome Atlas (TCGA) program and will support the U.S. Pediatric Photon Therapy Comparison...

The National Cancer Institute (NCI) awarded a $293,970 firm fixed-price purchase order to the University Health Network (UHN), doing business as the Toronto General And Western Hospital Foundation, to retrieve existing clinical and treatment data for at least 500 pediatric cancer patients treated with photon therapy since 2007. This data will be used to evaluate photon therapy as a cancer treatment for pediatric patients as part of the U.S. Pediatric Photon Therapy Comparison Cohort Study. The...

This is a $370,804.00 Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) at the U.S. Department of Health and Human Services (HHS), to Reveal Biosciences Inc. The contract is for the development of an image-based platform to comprehensively de-identify whole slide imaging (WSI) data for cancer research. This was a total small business set-aside contract. Reveal Biosciences is a computational...

This federal contract award was issued by the National Cancer Institute (NCI), a civilian agency under the Department of Health and Human Services, to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract, valued at $78,651,080, is a cost-plus-fixed-fee delivery order to support the NCI's clinical and research data sharing initiatives. The contract has no set-aside designation. Under this contract, Leidos Biomedical Research Inc. will develop a data federation...

The National Cancer Institute (NCI) awarded a $249,814 firm fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to establish the US Pediatric Proton and Photon Therapy Cohort. This retrospective cohort study will compare the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. The contractor will retrieve de-identified clinical and treatment data...

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a $202,500 firm fixed-price purchase order to Hamamatsu Corp, a for-profit organization, for a Hamamatsu NanoZoomer S360 high-throughput digital pathology slide scanner. This award was made under an unrestricted commercial item solicitation and does not involve any set-aside designations. The slide scanner will be delivered and installed within 60 days at the NIH campus...